F ew epidemiological studies have examined the associations between serum fatty acids, a biomarker of fatty acid intake, and ischemic stroke risk. 1 Thus far, the results have been inconsistent. One study conducted in Japan found that serum saturated fatty acids were associated with increased risk of ischemic stroke, whereas serum linoleic acid (an n6 polyunsaturated fatty acid) was associated with decreased risk. 2 Another study conducted in Finland found similar associations as the Japan study, but additionally reported that serum monounsaturated and n3 polyunsaturated fatty acids were associated with increased risk of ischemic stroke. 3 However, a third study found no significant associations for serum saturated or monounsaturated fatty acids. 4 Two possibilities have been raised that could explain these inconsistent findings. First, the associations between serum fatty acids and ischemic stroke may not be consistent for all ischemic stroke subtypes. In the Japan study described previously, the results were driven by lacunar stroke, this subtype comprising 95 of the 122 ischemic strokes in that study. 2 Importantly, this study did not have sufficient power to examine associations for atherothrombotic stroke, the subtype of ischemic stroke directly related to blood cholesterol. 5 Combining atherothrombotic stroke with lacunar and cardioembolic strokes would dilute expected associations. However, to our knowledge, only this Japan study has examined serum fatty acids in relation to atherothrombotic stroke and other ischemic stroke subtypes.
Second, the inconsistent findings could be because of individual fatty acids having different effects on ischemic stroke. In the Japan study described previously, despite finding that serum myristic and palmitic, but not stearic, saturated fatty acids were positively associated with total ischemic stroke in unadjusted analysis, investigators combined these 3 fatty acids in multivariable analysis. 2 Depending on the relative contribution of each fatty acid, it is possible to find inconsistent associations for total serum saturated fatty acids. However, few studies have examined serum fatty acids individually while controlling for potential confounders.
To clarify these possibilities, we conducted a prospective case-control study nested in a large cohort of postmenopausal US women to examine the associations between 25 individual serum fatty acid concentrations from stored serum samples collected at baseline and the incidence of ischemic stroke and ischemic stroke subtypes. We hypothesize that individual serum trans and saturated fatty acids would be positively associated with atherothrombotic stroke, whereas individual serum monounsaturated and polyunsaturated fatty acids would be inversely associated.
Methods

Study Population
We conducted a case-control study of 964 incident ischemic stroke cases and 964 matched control subjects nested within the Women's Health Initiative Observational Study (WHI-OS). 6 Briefly, the WHI was conducted in 40 clinical centers across the United States to examine the impact of several factors on the major causes of morbidity and mortality in postmenopausal women. 7 Eligible women were aged 50 to 79 years at baseline, were postmenopausal, had no medical conditions associated with a predicted survival of <3 years, and provided informed consent to be a part of the study as approved by the institutional review boards. The WHI-OS enrolled 93 676 women between October 1993 and December 1998. There were 972 confirmed incident ischemic stroke cases between 1993 and 2003. Control subjects were individually matched 1:1 to the cases on age and race at the time of ischemic stroke. Blood quantity was not sufficient to analyze fatty acid content for 9 participants, leaving a total of 964 case-control pairs.
Case Identification and Classification
Incident ischemic strokes during the follow-up period were identified through self-report during annual medical history updates (annual response rate 94%). 8 Using additional details from medical charts, brain imaging, or death certificates, the potential outcomes were subject to local adjudication by physicians, then central adjudication by trained neurologists, according to criteria. More than 95% of participant-reported stroke cases were classified based on computed tomographic or MRI findings. 9 Central adjudicators further classified ischemic strokes by subtypes according to the Trial of ORG 10172 Acute Stroke Trial (TOAST) Classification. 10 The TOAST classification focuses on the presumed underlying stroke mechanism, requires detailed investigations (such as brain computed tomography, MRI, angiography, carotid ultrasound, and echocardiography), and distinguishes 5 categories of stroke, which include large-artery atherothrombotic stroke, small-vessel lacunar stroke, cardioembolic stroke, other, and undetermined mechanism.
11 Probable and possible subtype determinations were combined in this report. Transient ischemic attack, hemorrhagic stroke, strokes not requiring hospitalization, and strokes not confirmed by central adjudication were not included as a stroke outcome.
Control Selection
Controls were sampled from women at risk at the time ischemic stroke events occurred during the follow-up period and matched 1:1 to case subjects on age at baseline (±2 years), race/ethnicity (white, black, Hispanic, Asian, American Indian, or other/unspecified), date of study enrollment (±3 months), and follow-up time.
Data Collection
Fasting blood samples were collected from all WHI-OS participants by clinical staff members following a standardized protocol for venipuncture at baseline. 12 Samples were centrifuged, separated by layers, frozen onsite at −70°C, and shipped to the central WHI repository for long-term storage. Serum fatty acids were analyzed at Dr Rhobert Evans' laboratory at the University of Pittsburgh. Fatty acids were extracted according to the general technique of Bligh and Dyer using 1, 2-dinonadecanoylsn-glycero-3-phosphocholine (Avanti Polar Lipids, Inc, Alabaster, AL; 50 µg of 19:0) as an internal standard. 13 The lipid extracts were resuspended in 1.5 mL of 14% boron trifluoride methanol and derivatized according to the procedure of Morrison and Smith.
14 The extracts were analyzed by capillary GC:column (SP-2380, 105 m×53 mm ID, 0.20-μm film thickness). The gas chromatograph was a Perkin Elmer Clarus 500 equipped with a flame ionization detector. Operating conditions were as follows: the oven temperature was 140°C for 35 minutes, then ramped at 8°C/min to 220°C, and held for 12 minutes. Both injector and detector temperatures were at 260°C, and helium, the carrier gas, was at 15 psi. Identification of components was by comparison of retention times with those of authentic standards (Sigma Chemical Co, St. Louis, MO). Duplicate samples and control pools were analyzed with each batch of samples. The coefficients of variation of fatty acids ranged from 3.1% to 13.2%. The Spearman correlation coefficients between dietary fatty acid intake (% of total fat intake assessed by a food frequency questionnaire) and serum fatty acid concentrations among noncases (both measured at baseline) were 0.53 for docosahexaenoic acid (DHA), 0.42 for eicosapentaenoic acid, 0.18 for docosapentaenoic acid (DPA), 0.16 for palmitic acid, 0.15 for linoelaidic acid, 0.07 for arachidonic acid, and 0.03 for oleic acid.
Participants completed sociodemographic and lifestyle questionnaires during baseline visits to a WHI clinical center. 12 Physical activity was assessed based on participant report about the frequency, intensity, and duration of walking, exercise, or recreational activity and summarized into total metabolic equivalent task hours per week. Certified clinic staff measured participant height, weight, and blood pressure. Height and weight were measured without shoes or heavy clothing and with pocket contents removed. Body mass index was calculated by dividing weight in kilograms by the square of height in meters. Following standardized procedures, blood pressure was measured twice after a 5-minute seated rest with a 30-second rest in between. The average of 2 blood pressure measurements was used in analysis. Hypertension was defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or self-report of antihypertensive medication use. Diabetes mellitus was defined as being on treatment for diabetes mellitus by self-report or having a fasting glucose level ≥126 mg/dL. Participants reported their history of smoking, diabetes mellitus, atrial fibrillation, angina, or revascularization (coronary bypass surgery or angioplasty of the coronary arteries), as well as current use of medications.
Lipoprotein profiles were assayed at Liposcience using nuclear magnetic resonance. Low-density lipoprotein cholesterol was calculated from high-density lipoprotein cholesterol, total cholesterol, and triglyceride concentrations among women who had a triglyceride value <400 mg/dL using the Friedewald equation. 15 Low-density lipoprotein cholesterol values were set to missing for those women whose triglyceride value was >400 mg/dL (n=35) or who were missing high-density lipoprotein cholesterol, total cholesterol, or triglyceride values (n=7).
Statistical Analysis
The McNemar χ 2 test was used to compare covariate proportions between ischemic stroke cases and controls. The paired Student t test was used to compare serum fatty acid concentration and covariate means between ischemic stroke cases and controls. The distributions of the serum fatty acids were highly skewed to the right. Therefore, we used the median as the measure of central tendency for descriptive statistics.
Conditional logistic regression was used to estimate odds ratios (OR) and 99.9% confidence intervals (CI) for ischemic stroke and its subtypes, conditioning on matching factors in all models. We divided women into quintiles based on distribution of serum fatty acid concentrations in the case-control study population. We estimated multivariable-adjusted ORs and 99.9% CIs comparing the odds of
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October 2013 ischemic stroke among women in the higher quintiles of serum fatty acids with the odds of ischemic stroke in the lowest quintile. Linear trend tests were performed by assigning the median value of the quintile of the fatty acid to each category and entering this variable into the model as a continuous variable. Because trends were generally linear, multivariable-adjusted ORs were calculated per 1-SD increment in each fatty acid. Our primary model was adjusted for body mass index, smoking status, diabetes mellitus, and aspirin use. Subsequent models were adjusted for blood pressure and blood cholesterol variables, because these factors are the likely mediators of the association between serum fatty acids and ischemic stroke. Two-sided P≤0.001 was considered significant to account for multiple comparisons and to decrease the risk of detecting a false-positive association (type I error). All analyses were performed using SAS statistical software (version 9.2, SAS Institute Inc, Cary, NC).
Results
Study Population
Between 1993 and 2003, we identified 964 cases of incident ischemic stroke. Of these, 96 were atherothrombotic strokes, 250 were lacunar strokes, 209 were cardioembolic strokes, 42 were ischemic strokes of other determined cause, 366 were ischemic strokes of undetermined cause, and 1 was missing subtype information. The mean age of women with ischemic stroke at baseline was 68.7 (SD, 6.4) years (Table 1) . Women with incident ischemic stroke were more likely to be overweight or obese, be a current smoker, have diabetes mellitus, and to use aspirin. We accounted for these differences by adjusting for these variables in multivariable-adjusted analysis.
Distribution of Serum Fatty Acids
Twenty-five individual serum fatty acids were examined ( Table 2 ). The major contributors (median >5%) to the composition of serum fatty acids were linoleic (27%), palmitic (24%), oleic (18%), stearic (9%), and arachidonic (8%) fatty ‡Diabetes mellitus was defined as having a fasting glucose level ≥126 mg/dL or being on treatment for diabetes mellitus by self-report.
(Continued) acids. The serum concentrations of 18:1t and linoelaidic trans fatty acids, myristic and palmitic saturated fatty acids, and 7-hexadecenoic and oleic monounsaturated fatty acids were higher among ischemic stroke cases than controls. The concentrations of α-linolenic, eicosatetraenoic, eicosapentaenoic acid, DPA, DHA n3 polyunsaturated fatty acids and linoleic, arachidonic, and 22:5n6 n6 polyunsaturated fatty acids were lower among ischemic stroke cases than controls.
Total Ischemic Stroke
With adjustment for body mass index status, smoking status, diabetes mellitus, and aspirin use and accounting for the matching factors, serum linoelaidic acid (18: (Figure 1 , Table I in the online-only Data Supplement). Further adjustment for blood pressure and blood cholesterol did not change estimates by >10%. Neither did further adjustment for physical activity, angina, atrial fibrillation, or revascularization change estimates by >10% (data not shown).
To examine the possibility that the positive association for serum oleic acid was because of its correlations with serum arachidonic acid or serum DHA (Spearman rank correlation coefficients −0.43 and −0.31, respectively), we additionally adjusted for these fatty acids using the residual method. 16 The multivariable-adjusted OR for total ischemic stroke associated with a 1-SD increment in oleic acid was attenuated by 9% after adjustment for serum arachidonic acid, by 10% after adjustment for serum DHA, and completely attenuated after adjustment for serum total polyunsaturated fatty acids (OR=1.00, 99.9% CI, 0.84-1.19). 
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Ischemic Stroke Subtypes
We further examined the fatty acids that were significantly associated with total ischemic stroke (serum linoelaidic acid, palmitic acid, oleic acid, DPA, DHA, and arachidonic acid) in relation to ischemic stroke subtypes. The associations between these serum fatty acids and total ischemic stroke were generally consistent for atherothrombotic stroke, lacunar stroke, and ischemic stroke of undetermined cause, except that we did not observe a positive association between palmitic acid and atherothrombotic stroke ( Figure 2 , Table II in the onlineonly Data Supplement). We did observe an inverse association between serum DHA and cardioembolic stroke, making DHA the only serum fatty acid to be consistently inversely associated with all subtypes of ischemic stroke. We did not have : Unadjusted models accounted only for the matching factors: age, race, and time on follow-up.
: Adjusted for BMI status (<25.0, 25.0 to 29.9, ≥30.0 kg/m 2 ), smoking status (never, past, current), diabetes, and aspirin use.
: Adjusted for the previous model variables plus systolic blood pressure and antihypertensive medication use.
: Adjusted for the previous model variables plus total cholesterol to HDL-C ratio and normalized-triglycerides.
Figure 1.
Odds ratios and 99.9% confidence intervals for total ischemic stroke associated with a 1-SD increment in individual serum fatty acids.
: Unadjusted models accounted only for the matching factors: age, race, and time on follow-up.
: Adjusted for the previous model variables plus total cholesterol to HDL-C ratio and normalized-triglycerides. sufficient statistical power to examine associations for ischemic strokes of other determined cause (42 matched pairs). Further adjustment for blood pressure attenuated associations for lacunar stroke (eg, by 10% for DHA) but not atherothrombotic stroke. Further adjustment for blood cholesterol attenuated associations for lacunar stroke (eg, by 37% for linoelaidic fatty acid) and atherothrombotic stroke (eg, by 82% for linoelaidic fatty acid, and reversed the associations for palmitic and oleic fatty acids).
Discussion
In this study, the largest case-control study of ischemic strokes among postmenopausal US women, serum linoelaidic (trans) acid, palmitic (saturated) acid, and oleic (monounsaturated) acid were associated with increased incidence of ischemic stroke. Serum DPA and DHA (n3 polyunsaturated) acids and arachidonic (n6 polyunsaturated) acid were associated with decreased incidence. These associations were generally consistent for atherothrombotic and lacunar stroke but not cardioembolic stroke.
Our results suggest that individual serum fatty acids have different associations with ischemic stroke. However, large prospective cohort studies have not been able to examine fatty acids individually. These studies assessed fatty acid intake through participant report of diet (eg, food frequency questionnaire), which can only distinguish major types of fat (eg, saturated fat). Two prospective studies reported that saturated fat intake and animal fat intake (mostly saturated fat) were associated with decreased risk of ischemic stroke and cerebral infarction death, respectively. 17, 18 However, 4 prospective studies failed to find associations between saturated fat intake and ischemic stroke. [19] [20] [21] [22] One possible explanation for these inconsistent results is that individual fatty acids, even those of the same type, may have different effects on cardiovascular disease risk. For example, myristic (14:0) and palmitic (16:0) acids tend to increase plasma total and low-density lipoprotein cholesterol concentrations compared with oleic acid, whereas stearic acid (18:0) does not. 23 It is possible that examining general types of fat intake masked the associations of individual fatty acids and ischemic stroke. However, individual fatty acids used in studies of dietary intake tend to be highly correlated. These high correlations make distinguishing their individual relationships with ischemic stroke risk difficult. 24 In contrast to the prospective studies using fatty acid intake derived from participant report of intake, case-control studies using biomarkers of fatty acid intake-serum, erythrocytes, and adipose tissue-are able to examine fatty acids individually (eg, palmitic acid). In the largest of these previous studies, Iso et al 2 found that serum myristic and palmitic acids, but not stearic acid, were associated with increased risk of ischemic stroke, although all 3 are saturated fatty acids. In addition, serum linoleic acid, but not other polyunsaturated fatty acids, was associated with decreased risk of ischemic stroke. Smaller case-control studies also suggest that individual fatty acids, even those of the same type, may have different effects on ischemic stroke risk. 4, [25] [26] [27] These studies highlight the importance of examining individual fatty acids in relation to ischemic stroke risk.
Our results also suggest that the associations between serum fatty acids and ischemic stroke may not be consistent across all ischemic stroke subtypes. To our knowledge, only 2 studies have reported associations for ischemic stroke subtypes. In these studies, the associations between individual fatty acids and total ischemic stroke were consistent for lacunar stroke but not for atherothrombotic or cardioembolic stroke. Iso et al 2 reported that the associations between serum saturated and linoleic fatty acids and ischemic stroke were driven by lacunar stroke, this subtype comprising 95 of the 122 ischemic strokes in that study. In a recent longitudinal study using data from the full WHI-OS cohort, we found that the positive association between dietary trans fat intake and ischemic stroke was consistent for lacunar stroke. But in that study, we were not able to examine the associations for individual fatty acids, and the statistic power was insufficient for examining atherothrombotic strokes. 22 Nevertheless, these prior studies highlight the importance of examining ischemic stroke subtypes separately.
The associations between fatty acids and ischemic stroke may not be consistent across all subtypes because ischemic stroke is a heterogeneous condition. There is evidence that blood cholesterol may play a role in the development of some ischemic stroke subtypes, but not others. 5 Kuller and Reisler 28 examined the incidence of ischemic stroke subtypes in populations with varying blood cholesterol levels. Based on this analysis, they hypothesized that blood cholesterol may play a role in atherothrombotic stroke, the ischemic stroke subtype with an atherogenic basis. Fatty acid intakes have a powerful effect on blood cholesterol concentrations, and they were hypothesized to play a role in the development of atherothrombotic stroke as well. One of the challenges in studying atherothrombotic stroke, the least prevalent ischemic stroke subtype, is low statistical power. However, we had sufficient power to detect general trends in atherothrombotic stroke incidence according to serum fatty acid concentration. Consistent with the hypothesis of Kuller and Reisler, linoelaidic, oleic, DPA, DHA, and arachidonic acids were associated with atherothrombotic stroke. Although the effect of fatty acid intake on blood cholesterol likely explains the associations for atherothrombotic stroke, the explanation for the apparent associations of lacunar stroke is not clear. However, a few possibilities can be proposed. First, intake of DHA may lower blood pressure. A metaanalysis of 36 randomized trials reported that fish oil supplementation lowered systolic and diastolic blood pressures by 3.5 and 2.4 mm Hg, respectively. 29 Importantly, serum DHA, which may have a stronger blood pressure-lowering effect than eicosapentaenoic acid, 30 was the only serum fatty acid that was consistently associated with all subtypes of ischemic stroke in the present study. Second, intake of DHA inhibits thrombosis through its antiplatelet effects. 31 In the present study, serum DHA was inversely correlated with D-dimer concentration, which is a measure of thrombotic disease such as lacunar stroke. Third, intake of trans fat and n3 polyunsaturated fatty acids has pro-and anti-inflammatory effects, respectively. 32, 33 High concentrations of inflammatory markers have been associated with greater neurological deterioration in lacunar strokes. 34 Finally, there is limited evidence suggesting
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that trans fat intake may adversely affect glucose tolerance, which may lead to development of diabetes mellitus, which is a major risk factor for lacunar stroke. Most observational studies report a positive association between trans fat intake and diabetes mellitus; however, these results have not been supported by the results of controlled feeding studies. 35 Our study has some limitations. One concern is the stability of serum fatty acids during storage and freeze/thaw procedures. However, serum storage for ≤12 years at −80°C protected polyunsaturated fatty acids, the most susceptible fatty acids to store and freeze/thaw, from oxidation. 36 We conducted an analysis of 15 samples analyzed originally in 2005, 1 year later in 2006, and then after an additional freeze/ thaw procedure. No statistically significant differences were detected between the mean values of the fatty acids from the original and 1-year or freeze/thaw samples. In addition, serum fatty acids may reflect diet only during a short period of time, and only 1 measure of serum was performed in the WHI. We make the assumption that the concentration of fatty acids in serum remains relatively stable over time.
When these ischemic strokes were classified, TOAST was the best currently available, with moderate-to-good interobserver reliability with training. 11 The field of ischemic stroke classification has been evolving to address the large number of cases that are classified as having undetermined cause. In the newer Atherosclerosis-small vessel disease-cardiac sourceother (ASCO) Phenotypic System, cases can be characterized by all 4 phenotypes based on the level of diagnostic certainty. 37 Using the ASCO classification could reduce the proportion of ischemic stroke cases with underdetermined cause and increase statistical power.
Another concern is that the TOAST classification uses a history of diabetes mellitus and hypertension in its lacunar stroke definition. 38 This classification bias could, in part, explain the association between serum fatty acid and lacunar stroke, assuming that serum fatty acids act through hypertension to increase risk of ischemic stroke. More recent studies have advocated the use of a risk factor-free classification to avoid classification bias. 5 However, the prevalence of hypertension among the ischemic stroke subtypes was relatively uniform (72% of atherothrombotic, 73% of lacunar, and 68% of cardioembolic stroke cases), suggesting that this misclassification was not a major source of bias in this study.
Finally, there is evidence that associations between fatty acid biomarkers and ischemic stroke may vary by the age of the study population and type of biomarker used. 3 The results derived from this study population of predominately white postmenopausal women may not be generalizable to other populations.
In conclusion, we report that serum linoelaidic trans fatty acid, palmitic saturated fatty acid, and oleic monounsaturated fatty acid were positively associated with incidence of ischemic stroke, whereas serum DPA and DHA n3 polyunsaturated fatty acids and arachidonic n6 polyunsaturated fatty acid were inversely associated with incidence of ischemic stroke. These associations were generally consistent for atherothrombotic and lacunar strokes. These findings highlight the importance of individual fatty acids in the development of particular subtypes of ischemic stroke. 
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